HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement
Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress
Source: investegate.co.uk
Page 3 - Zhou Yi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Zhou Yi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Zhou Yi Today - Breaking & Trending Today
Positive CHMP Opinion for Fruquintinib | Company Announcement
Investegate announcements from Positive CHMP Opinion for Fruquintinib
Source: investegate.co.uk
HUTCHMED Highlights Data to be Presented at AACR Congress 2024
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 -- HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will...
Source: marketscreener.com
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
— NDA accepted and both fruquintinib and sintilimab granted Priority Review, following Breakthrough Therapy designation in July 2023 — — First regulatory filing for fruquintinib for use in...
Source: marketscreener.com
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated ...
— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients —
Source: eagletribune.com